Discovery and Translational Sciences | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2022
2025
Known Financial Commitments (USD)
$4,094,561
Funder
Gates Foundation
Research Location
United Kingdom
Lead Research Institution
SpyBiotech Ltd
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

SpyVector: an antigen decorated adenovirus vector for a broadly cross-protective coronavirus vaccine

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Displayed and encoded antigens on adenovirus vectors optimize humoral and cellular immune responses in rhesus macaques.

Displayed and Encoded Antigens on Adenovirus Vectors Optimize Humoral and Cellular Immune Responses in Rhesus Macaques